GreenArt: Nutrikinetics and Bioavailability Studies
ConditionNutrition, Healthy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-69
SponsorFytexia
About this trial
The aim of this study is to investigate phenolic compounds from GreenArt, a baccharis-type propolis ingredient, bioavailability and nutrikinetics by measuring urinary excretion and metabolic profile over 48h by means of high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS). The study follows a cross-over, double-blind, randomized and placebo control design on 10 healthy subjects.
Eligibility criteria
Qualifiers
Provision of signed and dated informed consent form.
Stated willingness to comply with all study procedures and availability for the duration of the study.
Male and female with 40% min. and 60% max. of each sex.
Aged 25 to 69 years old
Disqualifiers
Current use of any medication or food supplement
Antibiotic use less than 12 weeks before the study
Pregnancy or lactation
Known allergic reactions to components of the supplement, i.e., bee products (specially propolis) and known allergy (general)
Trial design
Treatments tested in this trial
- GreenArt D is a baccharis-type propolis powder extract containing phenolic compounds such as prenylated phenylpropanoids derived from hydroxycinnamic acids and flavonoids.
- GreenArt 4D is a baccharis-type propolis powder extract containing phenolic compounds such as prenylated phenylpropanoids derived from hydroxycinnamic acids and flavonoids.
- Placebo
Treatment groups
10 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov